Please provide your email address to receive an email when new articles are posted on . IVUS may improve care of patients undergoing peripheral revascularization. More data are needed to document ...
Stryker announced that it has signed a definitive agreement to acquire Amplitude Vascular Systems, Inc. (AVS), which is a private ...
Stryker (NYSE:SYK), a global leader in medical technologies, announced that it has signed a definitive agreement to acquire Amplitude Vascular Systems, Inc. (AVS), a privately held medical technology ...
Please provide your email address to receive an email when new articles are posted on . In a cohort of patients with renal impairment who underwent peripheral revascularization, rivaroxaban reduced ...
Compared with dipeptidyl peptidase-4 (DPP-4) inhibitors, sodium-glucose cotransporter 2 (SGLT2) inhibitors were associated with lower risks of cardiac death and composite renal outcomes without ...
SYK to acquire Amplitude Vascular Systems, adding next-gen IVL tech to boost its peripheral vascular portfolio and expand ...
WASHINGTON, DC—Vascular interventions in patients with PAD are associated with comparable short-term outcomes no matter whether they’re performed via radial or femoral access, according to early ...
Compared with white patients, Black patients with PAD who undergo peripheral revascularization have much more advanced disease at the time of their procedures and are less likely to receive necessary ...
"Our findings highlight the clinical importance of focusing on total disease burden, rather than first events, and the need for long-term preventive strategies in high-risk patients."—Michael Szarek, ...
The acquisition will enable Stryker to expand its portfolio with intravascular lithotripsy technology from Amplitude Vascular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results